1 Data sources
GWAS data
We analyzed two GWAS data sets: NFBC1966 study [14] and Genetic Epidemiology Research on Aging (GERA) [8] . The NFBC1966 data set contains information for 5,402 individuals with a selected list of phenotypic data related to cardiovascular disease including multiple metabolic traits (high-density lipoprotein cholesterol, HDL-C; low-density lipoprotein cholesterol, LDL-C; total cholesterol, TC; triglycerides, TG; C-reactive protein, CRP), glucose, insulin, body mass index (BMI), systolic and diastolic blood pressure (SysBP and DiaBP), and 364,590 SNPs genotyped.
The GERA data set contains information for 62,313 European individuals with 657,184 SNPs genotyped. The health conditions in participants have been derived from numerical coded diagnoses in electronic medical records. The disease statuses include asthma, allergic rhinitis, DE-PRESS, DYSLIPID, hernia abdominopelvic, hemorrhoids, insomnia, iron deficiency, irritable bowel syndrome, MACDEGEN, osteoporosis, PVD, peptic ulcer, STRESS, varicose veins.
We performed strict quality control on data using PLINK [13] . We excluded individuals having discrepancies between reported sex and sex determined from the X chromosome. We excluded SNPs with a minor allele frequency less than 1%, having missing values in more than 1% of the individuals or with a Hardy-Weinberg equilibrium p-value below 0.0001. After quality control, 5,123 individuals with 319,147 SNPs in NFBC1966. For GERA data set, we removed individuals with the same family ID in addition. In total, 59,576 individuals with 550,482 SNPs in GERA were remaining for the further analysis.
Transcriptome data
The Genetic European Variation in Health and Disease (GEUVADIS) Project [9] provided mRNA and small RNA sequencing on 465 Epstein-Barr-virus-transformed lymphoblastoid cell lines samples whose DNA sequencing data can be available from the 1000 Genomes Project [2] . In this study, we 3 only used 379 individuals from European ancestry in the 1000 Genome Project, including British in England and Scotland, Finnish in Finland, Toscani in Italy and Utah residents with Northern and Western European ancestry. Since the original gene expression measurements are read counts , the PEER normalization [16, 17, 1] was applied to remove technical variations and batch effects.
We quantile-normalized every gene expression to a standard normal distribution separately in the five populations and then quantile-normalized them together. According to GENCODE (release 12) [7] , we selected 15,810 genes in the GEUVADIS data set that were expressed in at least half of the individuals. For each gene, we only included the common (minor allele frequency >= 0.05) variants within 500kb of the transcription start and end of each protein coding gene (according to GENCODE release 12 gene annotation), resulting in 550 variants on average included for one gene.
Implementation details of related methods

PrediXcan
In this section, we briefly summarize how PrediXcan [6] utilizes reference transcriptome data and GWAS data for GWAS analysis. There are two steps in PrediXcan:
• Step one (imputation step): It uses elastic net to build the predictive model (û 0 ,û) = arg min u 0 ,u
where α = 0.5 (by default) and λ is tuned by cross-validation. Gene expression levels for the individuals in the GWAS data are predicted asŷ 2,g =û 0 + W 2gû , where W 2g is the corresponding genotype matrix in D 2 .
•
Step 2 (association analysis step): Association between z andŷ 2,g is examined by simple linear regression: z = α gŷ2,g + α g0 , where α g0 is the intercept and α g is the coefficient for the g-th gene, and standard statistical inference follows.
In PrediXcan, the imputation and association analysis steps are conducted separately. Consequently, the association analysis treats the predicted expression valuesŷ 2,g as if they were observed 4 without error, and does not account for the uncertainty associated with the imputation step. This leads to an underestimate of the coefficient α g , a phenomenon known as attenuation bias in measurement error models (MEM) [5] . In order to correct for attenuation bias in the framework of MEM, the variance of the predicted values has to be known [3] . However, estimation of this variance is challenging in this context due to the prior model selection using elastic net [4] .
We implemented PrediXcan using glmnet package in R. In the first stage, we use elastic net (α = 0.5) or ridge (α = 0) to build the predictive model using transcriptome data. In the second stage, the predictive model fitted in stage one is used to calculate the predicted levels of gene expression for the individuals in the GWAS data. In the third stage, linear models are fitted for the phenotype and the predicted gene expressions to conduct genome-wide scan. For a fair comparison of PrediXcan, RL-SKAT and CoMM, we consider cis-SNPs only within 500 Kb of a gene.
SKAT
For the popular score-based Sequence Kernel Association Test (SKAT) method, its score test statistic has been shown uncalibrated in small samples [15] . To make a fair comparison with SKAT, we used RL-SKAT which is an exact and efficient Score Test. RL-SKAT is available at Github in Python and it is re-implemented in R as a function within package CoMM.
Normalization of gene expressions
One common approach in the field was to use PEER/PC normalization with one quantile normalization step to make the expression residual levels normally distributed across genes. This one step of quantile normalization ensures that the normality model assumption in PrediXcan satisfied.
We have generally followed this standard approach, but with one additional quantile normalization step added in the present study to account for the fact that there are multiple populations in the GEUVADIS data. Specifically, for each gene in turn, we performed the first quantile normalization across individuals within each population separately. This first normalization ensures equal mean 5 gene expression levels across all populations and removes potential expression difference due to population stratification. This first quantile normalization is equivalent to including population labels as covariates in subsequent models. Afterwards, for each gene in turn, we performed an additional quantile normalization across all individuals. This second quantile normalization is the same as used in traditional approaches, and ensures that the expression levels are normally distributed so that the modeling assumptions for the PrediXcan or CoMM methods are satisfied. Our two-step quantile normalization approach follows closely that of [18] and is designed to account for population stratification in the data. However, we do acknowledge that the first quantile normalization may be overly conservative: indeed, previous studies (e.g. [9, 11] ) have shown that only ≈ 3% of gene expression variance is due to population labels in the GEUVADIS study. We eventually used the two quantile normalization to be on the conservative side. Regardless which normalization procedure was used, we also note that all methods are compared on the same processed data, so method comparison in the real data is still valid.
Comparison of PX-EM and EM
We conducted simulation studies to evaluate efficiency of the PX-EM algorithm in comparison with the standard EM algorithm. We varied n 1 to be 400 and 800 and n 2 from 5,000 to 200,000.
In all these settings, the number of SNPs within a gene (M g ) is 100 or 200. We fixed ρ = 0.5, h 2 C = 0.03, h 2 T = 0.003 and beta sparsity to be 0.2. We set the stopping criteria to be the same across all settings. Here, we use median of computational time and the number of iterations to make comparisons. As shown in Figure S1 , the PX-EM algorithm generally converges in much less iterations than EM, with nearly the same order of cost in each iteration. Hence, the computational gain from the developed PX-EM algorithm is substantial ('Time panel' in Figure S1 ). Algorithm 1: PX-EM algorithm for model (5) Initialization: Parameters regarding transcriptome data set can be initialized using linear mixed model (σ 2 1 , σ 2 u ), α g = 0, β = (X X) −1 X z and γ = 1. repeat E-step: At the t-th iteration, the posterior distribution q(u|θ (t) ) of u is Gaussian with mean and variance given by expressions (7) with γ = γ (t) = 1, other parameters are given as α g = α
u ) 2 , where the superscript (t) indicates the t-th iteration. Then the Q function can be evaluated as expression (9) . M-step: The updating equations can be obtained by setting ∂Q ∂θ = 0 which are solved by expressions (10) .
) 2 and then reset γ: γ (t+1) = 1. until maximum iteration reached ;
An intuitive explanation of the PX-EM algorithm
The PX-EM algorithm was first proposed by Liu, Rubin and Wu [10] To have an intuitive idea, we first introduce some notations. Let θ be the set of parameters in an EM algorithm and L(θ) be the marginal log-likelihood function. In the PX-EM algorithm, suppose this parameter set is expanded by γ and then the new set of parameters becomes as {θ, γ}, whereθ is the corresponding part to θ in the EM algorithm. In parameter expanded verision, we denote its log-likelihood as L X (γ,θ), where the subscript X indicates the parameter expanded version. Based on the definition of PX-EM algorithm, L X (γ = γ 0 ,θ = θ) = L(θ), where γ 0 is called 'null value' of γ. In particular, there exist infinite number of parameter combination (γ ,θ ) in the expanded parameter space such that In this model, we have the null value γ 0 = 1 and θ = {σ 2 u }. In particular, we have Now suppose we have current parameter estimate, denoted as θ old , standard EM will update it as θ (EM ) , as inidicated by the arrow from point A to point B, in the left panel of Figure S2 .
For PX-EM, it will first optimize L(γ,θ) in the expanded space (γ,θ), as indicated by the arrow from point A to point C. Then the reduction step of PX-EM will map point C to point D because
, where the subscript C indicates the parameter values given at point C in Figure S2 . Back to the original parameter space (The right panel of Figure S2 ), the standard EM achieves the maxmum of its lower bound (blue curve), i.e., point B. The PX-EM will not stop at point B but make adjustment based the covariance of current estimate in the expanded space, leading to further increase of L(θ). It is worth noticing that PX-EM does not aim to achieve the maximum of the lower bound in the orignial paramter space but the maximum of lower bound in the expanded space. At last, we conclude with a comparsion of PXEM and EM on a classical random-effect model in Figure S3 . 
Comparsion of LRT and Wald test
We derived the Wald test for CoMM and compared it with the likelihood ratio test (LRT). We conducted simulation studies for two cases: sample size of transcriptome data is relatively small Here, we just sketch the skeleton of the Wald test for CoMM. The complete-data log-likelihood can be written as equation (6) . For the model using EM algorithms, the Fisher's information for the parameters (θ)) is derived based on the Louis's method [12] . The Fisher's information for the incomplete log-likelihood can be computed by
where S c is the vector of score function for the complete-data log-likelihood and I c is the Fisher's information for the complete-data likelihood.
where
S c (θ) is the partial derivative of the complete-data log-likelihood with respect to θ (here θ is a 
where L c is the complete-data log-likelihood. Then, we can derive the Fisher's information matrix The second line of equation (S4) with a scaling constant is
Note that we use E(xx
The third line of equation (S4) with a scaling constant is
Note that E(W 2g uu T W T 2g W 2g u) can be evaluated as the second line and
can be evaluated as equation (S3).
• Notes:
Combine Part 1 and Part 2, we can evaluate the Fisher's information for incomplete data (S2) and calculate the standard errors for α g correspondingly. Figure S13 : The Manhattan plots of BMI, Glucosem, Insulin, SysBP and DiaBP in NFBC using CoMM, PrediXcan:Ridge, PrediXcan:Enet and SKAT. Figure S17: The Manhattan plots of hemorrhoids, hernia abdominopelvic, insomnia and iron deficiency in GERA using CoMM, PrediXcan:Ridge, PrediXcan:Enet and SKAT.
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